EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[°£ÈíÃæ. °£ÈíÃæÁõ. Clonorchis sinensis] - ðû

1. ¿ªÇÐ

2. º´Å»ý¸®

3. ÀÓ»ó»ó

4. Áõ·Ê

5. FAQ

6. References


1. ¿ªÇÐ

°£ÈíÃæÀº ÇöÀç ¿ì¸®³ª¶ó¿¡¼­ °¡Àå Áß¿äÇÑ Àå³» ±â»ýÃæÀÔ´Ï´Ù.


2. Pathophysiology

°£ÈíÃæ(Clonorchis sinensis)Àº 1 cm Å©±âÀÇ ³ª¹µÀÙ ¸ð¾ç ÈíÃæÀÔ´Ï´Ù. ¸ð¾çÀÌ ºñ½ÁÇÑ °£Áú(Fasciola hepatica)Àº 2-3 cmÀÔ´Ï´Ù. °£ÈíÃæÀº ¹Î¹°°í±â¸¦ ³¯·Î ȤÀº ´úÀÍÇô ¸Ô¾î¼­ °É¸³´Ï´Ù. ºØ¾î, À×¾î, Çâ¾î, ¸ð·¡¹«Ä¡, ÇǶó¹Ì, ²©ÁöÀÇ ±ÙÀ°¿¡ ÀÖ´Â °£ÈíÃæÀÇ metacercaria(Çdz¶À¯Ãæ)°¡ ¿øÀÎÀÔ´Ï´Ù.

°£ÈíÃæ À¯ÃæÀÌ ÀÎü¿¡¼­ ¼ºÃæÀ¸·Î ¹ßÀ°ÇÏ¿© small to medium-sized bile duct¿¡ ±â»ýÇÕ´Ï´Ù. °£È¤ º¸´Ù Å« ´ãµµ³ª ´ã³¶¿¡¼­ ¹ß°ßµÇ±âµµ ÇÏÁö¸¸ °£½ÇÁúÀº ħÀ±ÇÏÁö ¾Ê½À´Ï´Ù. ´ãµµÀÇ adenomatous hyperplasia¿Í periductal inflammation/fibrosis¸¦ ÀÏÀ¸Åµ´Ï´Ù. °á±¹ ÀÛÀº ´ãµµ°¡ ¸·È÷°í È®ÀåµÇ¾î ÃÊÀ½Æİ˻翡¼­ diffuse peripheral bile duct dilatationÀ¸·Î º¸ÀÌ°Ô µË´Ï´Ù. ÀÎü¿¡¼­ 20³â ÀÌ»ó ±â»ýÇÒ ¼ö ÀÖÀ¸¸ç cholelithiasis, cholecystitis, cirrhosis, cholangiocarcinoma µîÀ» ÀÏÀ¸Åµ´Ï´Ù. Áï Áß¿äÇÑ carcinogenÀÎ ¼ÀÀÔ´Ï´Ù.

   


3. ÀÓ»ó»ó

¿ì¸®³ª¶ó¿Í °°Àº À¯ÇàÁö¿ª¿¡¼­´Â ´ëºÎºÐ °¨¿°ÀÚ°¡ ¹«Áõ»óÀÔ´Ï´Ù.½ÉÇÑ ±Þ¼º °¨¿°ÀÇ °æ¿ì¿¡´Â ¹«±â·ÂÁõ, Ȳ´Þ, º¹¼ö, º¹Åë, ¼ÒÈ­ºÒ·®, ¹ß¿­, eosinophilia, hepatomegaly°¡ °¡´ÉÇÕ´Ï´Ù.

´ëº¯°Ë»ç¿¡¼­ Ãæ¶õÀ» °ËÃâÇÔÀ¸·Î½á È®ÁøÇÒ ¼ö Àִµ¥ ¸¸¼º °¨¿°½Ã¿¡´Â Ãæ¶õ»êÃâ·®ÀÌ Àû¾îÁ® °ËÃâ·üÀÌ ³·½À´Ï´Ù. ELISA¸¦ ÀÌ¿ëÇÑ Ç÷û°Ë»ç¿Í Çdz»¹ÝÀÀ°Ë»ç°¡ °¡´ÉÇÏÁö¸¸ ±³Â÷¹ÝÀÀÀÌ ¸¹°í ÇöÁõ¿©ºÎ°¡ ¸íÈ®ÇÏÁö ¾Ê¾Æ Áø´Ü¸ñÀûÀ¸·Î »ç¿ëÇϱ⠾î·Æ½À´Ï´Ù.

Ä¡·á´Â praziquantel 25mg/kgÀ» 1ÀÏ 3ȸ, 1ÀÏ°£ Åõ¾àÇÏ¸é °ÅÀÇ 100% ¹Ú¸êµË´Ï´Ù. ±¹³»¿¡´Â [µð½ºÅä½Ãµå]¿Í [ºôÆ®¸®½Ãµå]¶ó´Â 2°³ÀÇ »óÇ°¸íÀ¸·Î ½ÃÀå¿¡ ³ª¿Í ÀÖÀ¸¸ç 600mg tablet 8°³°¡ ÇϳªÀÇ ¹Ú½º¿¡ Æ÷ÀåµÇ¾î ÆǸŵ˴ϴÙ. º¸Åë ¾Æħ 3¾Ë, Á¡½É 3¾Ë, Àú³á 2¾ËÀ» Åõ¾àÇÕ´Ï´Ù.

°£ÈíÃæ °¨¿°ÀÚ´Â Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¿©·¯ ÀÌÀ¯°¡ ÀÖ´Ù°í »ý°¢µË´Ï´Ù. (1) Á¾Àüº¸´Ù ´ã¼ö¾îÀÇ »ý½ÄÀÌ ¸¹¾ÆÁö´Â °æÇâÀÔ´Ï´Ù. (2) ´ëº¯°Ë»ç ÀÇ·Ú °Ç¼ö°¡ ÁÙ°í ÀÖ½À´Ï´Ù. (3) ´ëº¯°Ë»ç¸¦ ÀÇ·ÚÇصµ ȯÀÚµéÀÌ °Ëü¸¦ Á¦ÃâÇÏÁö ¾Ê´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. (4) »çȸ ÀüüÀûÀ¸·Î ±â»ýÃæÁõ¿¡ ´ëÇÑ °ü½ÉÀÌ ÁÙ¾îµç °Íµµ Å« ¹®Á¦ÀÔ´Ï´Ù.

ERCP¿¡¼­ ¹ß°ßÇÑ °£ÈíÃæ

´ã¼®À¸·Î ´ã³¶ÀýÁ¦¼ú. ´ã³¶¿¡ °£ÈíÃæÀÌ °¡µæ Â÷ ÀÖ¾úÀ½.

Intraductal cholangiocarcinoma ȯÀÚÀÇ bile cytology¿¡¼­ °£ÈíÃæÀÌ ³ª¿ÔÀ½

º¹ºÎ CT °Ë»ç¿¡¼­ ¿ì¿¬È÷ peripheral bild duct dilationÀÌ ¹ß°ßµÇ±âµµ ÇÕ´Ï´Ù. Stool examÀ» ÇÏ¸é °£È¤ °£ÈíÃæÁõÀÌ È®ÀεDZ⵵ ÇÕ´Ï´Ù.


2021³â 8¿ù À忬±¸ÇÐȸ Áõ·ÊÀÔ´Ï´Ù. üÁß°¨¼Ò·Î ³»¿øÇÏ¿´°í ȸÀå¿¡ ±Ë¾çÀÌ ÀÖ¾ú°í capsule endoscopy¿¡¼­ °£ÈíÃæÀÌ º¸¿´½À´Ï´Ù.


4. Áõ·Ê

[2014-12-14] GI & Hepatology News 2014³â 10¿ùÈ£(Çѱ¹ÆÇ) °­³²¼¼ºê¶õ½º º´¿øÀÇ Áõ·Ê

°Ç°­°ËÁø¿¡¼­ ¿ì¿¬È÷ ¹ß°ßÇÑ ´ãµµÈ®ÀåÁõ¿¡ ´ëÇÑ ¿øÀÎÀ» ERCP¸¦ Çϸ鼭 brush cytology¸¦ ÅëÇÏ¿© °£ÈíÃæÀ¸·Î Áø´ÜÇÑ ¿¹ÀÔ´Ï´Ù.


[FAQ]

[2012-6-8. ¾Öµ¶ÀÚ Áú¹®]

°£ÈíÃæ(Clonorchis sinensis)¿¡ ´ëÇÏ¿© praziquantelÀ» Åõ¾àÇߴµ¥ ´ëº¯°Ë»ç¿¡¼­ °è¼Ó Ãæ¶õÀÌ ³ª¿É´Ï´Ù. ¾î¶»°Ô ÇØ¾ß Çմϱî?

[2012-6-8. ÀÌÁØÇà ´äº¯]

Praziqantel·Î Çѹø ´õ Ä¡·áÇØ º¸°í ±×·¡µµ ¾ÈµÇ¸é albendazoleÀ» ½á º¸½Ê½Ã¿ä.

äÁ¾ÀÏ ±³¼ö´ÔÀÇ "ÀÓ»ó±â»ýÃæÇÐ" 366ÂÊ¿¡´Â ÀÌ·¸°Ô ³ª¿Í ÀÖ½À´Ï´Ù. "PraziquantelÀº 25mg/kgÀÇ ¿ë·®À» ÇÏ·ç 3ȸ °æ±¸Åõ¿©ÇÏ´Â °ÍÀ» ±âº»À¸·Î ÇÑ´Ù. À¯ÇàÁö¿¡¼­´Â ¹Ýº¹ÀûÀÎ ±¸ÃæÁ¦ Åõ¿©°¡ ÇÊ¿äÇÏ´Ù. ÇÏ·ç º¹¿ëÀ¸·Î Ä¡À¯µÇÁö ¾Ê´Â °æ¿ì¿¡ °°Àº ¿ë¹ýÀ¸·Î ¹Ýº¹ Åõ¾àÇÑ´Ù. AlbendazoleÀ» »ç¿ëÇÏ´Â °æ¿ì ÇÏ·ç¿¡ 5mg/kg¾¿ 2ȸ, 7ÀÏ°£ º¹¿ëÇÏ¿©¾ß È¿°ú°¡ ÀÖ´Ù."


[2012-7-1. ¾Öµ¶ÀÚ Áú¹®]

¿ì¸®°¡ ¹Î¹°È¸¸¦ ¸ÔÀ¸¸é Çdz¶À¯ÃæÀÌ ¼ÒÀå¿¡¼­ Å»³¶Çϸ鼭 ´ãµµ·Î µé¾î¿Í¼­ °£ÈíÃæÀÌ ±â»ýÇÏ°Ô µÇ´Âµ¥ Ȥ °£ÈíÃæ ¿¹¹æÇϱâ À§ÇØ ¹Î¹°È¸¿Í µ¿½Ã¿¡ ÇÁ¶óÁöÄäÅÚÀ» ¸ÔÀ¸¸é ¿¹¹æÀÌ µÇ³ª¿ä? Âü°í ¹®ÇåÀÌ ¾ø¾î¼­...

[2012-7-1. ÀÌÁØÇà ´äº¯]

PraziquantelÀº ¼¼Æ÷¸·ÀÇ Ä®½· Åõ°ú¼ºÀ» Áõ°¡½ÃÄÑ, ¼¼Æ÷³» Ä®½·ÀÇ ¼Õ½ÇÀ» °¡Á®¿É´Ï´Ù. ÀÌ´Â Ãæü ±ÙÀ°ÀÇ ¼öÃà°ú Ç¥ÇÇ ¼Õ»ó ¹× ¸¶ºñ¸¦ À¯µµÇØ Ãæü¸¦ Á×°Ô ÇÕ´Ï´Ù. PriziquantelÀÌ °£ÈíÃæÀÇ À¯Ãæ¿¡µµ ÀÛ¿ëÇÏ´ÂÁö´Â Àúµµ ÀÚ½ÅÀÌ ¾ø½À´Ï´Ù. Chemotherapeutic efficacy of praziquantel in rats with protective immunity to Clonorchis sinensis infection¶ó´Â Á¦¸ñÀÇ µ¿¹°½ÇÇè ³í¹®À» º¸¸é "Praziquantel was more effective against C. sinensis larvae than against adult worms"¶ó´Â ¸»ÀÌ ³ª¿É´Ï´Ù. ¾Æ¸¶µµ À¯Ãæ¿¡µµ ÀÛ¿ëÇÏ´Â °Í °°½À´Ï´Ù. ¹®Á¦´Â ¹Î¹°È¸¿Í praziquantelÀ» µ¿½Ã¿¡ ¸Ô¾úÀ» ¶§ ¼ÒÀå¿¡¼­ Å»³¶ÇÑ À¯Ãæ¿¡°Ô praziquantelÀÌ Àß Àü´ÞµÇ´ÂÁö pharmacokineticsÀ» ¾Ë ¼ö ¾ø´Ù´Â °ÍÀÔ´Ï´Ù.

¼­¿ï´ëÇб³ ±â»ýÃæÇб³½Ç È«¼ºÅ ±³¼ö´ÔÀÇ ÃÖ±Ù ¸®ºä Clonorchis sinensis and clonorchiasis, an update¸¦ ¼Ò°³ÇÕ´Ï´Ù. Mass control programÀÌ ÀÖ´Â ¸ð¾çÀε¥ È¿°ú°¡ ¾ÆÁÖ ÁÁÁö´Â ¾ÊÀº ¸ð¾çÀÔ´Ï´Ù.

In control programs of clonorchiasis by mass chemotherapy with PZQ, the control efficacy is lower than the known cure rate of PZQ. The low efficacy is due to treatment failure in a certain proportion by different drug metabolism and pharmacokinetics, incomplete medication practice of 3 doses, and re-infection after cure. In this context, education of target population is strongly recommended during the PZQ mass treatment. The education should include proper medication recipe of PZQ and change of their eating habit of raw fish.

Àú´Â ¹Î¹°È¸¿Í ÇÔ²² praziquantelÀ» ¸Ô´Â ¹æ¹ýÀ» ÃßõÇÒ ¼ö ¾ø½À´Ï´Ù. ¹Ù¸¥ ¹æ¹ýÀÌ ¾Æ´Ï±â ¶§¹®ÀÔ´Ï´Ù. Endemic area¿¡¼­´Â ¹Î¹°°í±â¸¦ ³¯·Î ¸ÔÁö ¾Ê´Â °ÍÀÌ ¹Ù¸¥ ¹æ¹ýÀ̶ó°í »ý°¢ÇÕ´Ï´Ù.

[2014-7-3. ¾Öµ¶ÀÚ ´äº¯]

´äÀå ´ë´ÜÈ÷ °¨»çÇÕ´Ï´Ù. ¸¹Àº °ÍÀ» ¾Ë°Ô µÇ¾î ±â»Þ´Ï´Ù. ¼ºÃæ°ú À¯Ãæ¿¡ È¿°úÀûÀÌÁö¸¸, ¼ÒÀå¿¡¼­ Å»³¶ÇÑ À¯Ãæ¿¡°Ô´Â ¾î¶²Áö´Â ¾Ë ¼ö°¡ ¾ø´Â °ÍÀÌÁö¿ä. ¹Î¹°È¸¿Í °°ÀÌ ¸Ô´Â °ÍÀº ¼±»ý´Ô ÀÇ°ß°ú ¼­¿ï´ë È« ¼±»ý´ÔÀÇ ÀÇ°ßó·³ ¿ë·® ºÎÁ· µîÀ¸·Î È¿°ú°¡ ÀÖ´Ù°í Çصµ ¹Ì¹ÌÇÒ °ÍÀ¸·Î »ý°¢µÇ¸ç, Áø´Üµµ µÇÁö ¾Ê´Â »óÅ¿¡¼­ ¸Ô´Â ¿À³²¿ëÀÌ°ÚÁö¿ä. ¹Î¹°È¸ ³¯°Í ¼·Ãë ±ÝÁö Âù¼ºÇÕ´Ï´Ù. ¹Ù»Ú½Åµ¥ ´äº¯ °¨»çÇÏ°í Ç×»ó °¨»çµå¸³´Ï´Ù. À帶ºñ°¡ ½ÃÀ۵Ǿú³×¿ä ¹«´õ¿î ¿©¸§ °Ç°­Çϼ¼¿ä.


[2017-4-24. ¾Öµ¶ÀÚ Áú¹®]

¸ÅÀÏ ÁÁÀº Áö½ÄÀ» ÀüÇØÁּż­ °¨»çÇÕ´Ï´Ù. ¿µ»óÀÇÇаú¿¡¼­ °£ÃÊÀ½ÆÄ ÈÄ peripheral bile duct°¡ ´Ù¼Ò ´Ã¾î³ª º¸¿© r/o clonorchis sinensis·Î ¿À½Å ºÐµéÀÌ °è½Ê´Ï´Ù. ´ëº¯°Ë»ç¿¡¼­ ±â»ýÃæÀÌ º¸ÀÌÁö ¾Ê´Â °æ¿ì°¡ ¸¹Àºµ¥, ÀÌ·± °æ¿ì °£ÈíÃæ Ä¡·á¸¦ ÇϽôÂÁö¿ä? ±×¸®°í ÃÊÀ½ÆÄ follow-up¸¦ Á¤±âÀûÀ¸·Î ÇϽôÂÁö ±Ã±ÝÇÕ´Ï´Ù.

[2017-4-30. ÀÌÁØÇà ´äº¯]

°£ÈíÃæÁõÀÇ ÃÊÀ½ÆÄ, CT, MRI ¼Ò°ßÀº ÃÖµ¿ÀÏ ±³¼ö´Ô Á¾¼³ (Choi D. Korean J Parasitol 2007)°ú ÀÓÀçÈÆ ±³¼ö´Ô Á¾¼³ (Lim JH. Abdom Imaging 2008)¿¡ Àß ³ª¿Í ÀÖ½À´Ï´Ù. °£ÈíÃæÀÌ small to medium-sized bile duct¿¡ ±â»ýÇϸ鼭 ´ãµµ¸¦ ¸·±â ¶§¹®¿¡ diffuseÇÑ peripheral bile duct dilatationÀ» º¸Àδٰí ÇÕ´Ï´Ù.

Parasitic infection of the biliary tree is caused by liver flukes, namely Clonorchis sinensis and Opisthorchis viverrini. These flukes reside in the peripheral small bile ducts of the liver and produce chronic inflammation of the bile duct, bile duct dilatation, mechanical obstruction, and bile duct wall thickening. On imaging, peripheral small intrahepatic bile ducts are dilated, but the large bile ducts and extrahepatic bile ducts are not dilated or slightly dilated. There is no visible caused of obstruction. Sometimes, in heavy infection, adult flukes are demonstrated on sonography, CT or MR cholangiography as small intraluminal lesions. The flukes in the gallbladder may appear as floating, small objects on sonography. Chronic infection may result in cholangiocarcinoma of the liver parenchyma or along the bile ducts. (Lim JH. Abdom Imaging 2008)

¿µ»óÀÇÇаú ÀÇ»çÀÎ ÃÖµ¿ÀÏ ±³¼ö´ÔÀº ¿µ»ó ¼Ò°ß¿¡ ±âÃÊÇÑ praziquantel Åõ¾àÀ» ÃßõÇÑ ¹Ù ÀÖ½À´Ï´Ù.

"Residents living in the endemic areas of clonorchiasis, who show images of diffuse dilatation of the intrahepatic bile ducts but have no history of specific medication, should be recommended to take praziquantel for treatment." (Choi D. Korean J Parasitol 2007)

¹®Á¦´Â °ËÁø¿¡¼­ °æ¹ÌÇÑ diffuseÇÑ peripheral bile duct dilatation ¼Ò°ßÀÇ specificity°¡ ¸íÈ®È÷ ¹àÇôÁöÁö ¾Ê¾Ò´Ù´Â °ÍÀÔ´Ï´Ù. °Ô´Ù°¡ ÇöÀç °¨¿°°ú °ú°Å °¨¿°µµ ±¸ºÐµÇÁö ¾Ê½À´Ï´Ù. ¿µ»ó¿¡¼­ ÀǽɵǴõ¶óµµ ´ëº¯ °Ë»ç¿¡¼­ °£ÈíÃæ Ãæ¶õÀÌ È®ÀεǴ ¿¹´Â ¸¹Áö ¾Ê½À´Ï´Ù. µû¶ó¼­ ¸ðµç ȯÀÚ¿¡°Ô praziquantelÀ» Åõ¿©ÇØ¾ß ÇÏ´ÂÁö ¾ÆÁ÷ ¸íÈ®ÇÏÁö ¾Ê½À´Ï´Ù.

Àú´Â ¹Î¹°°í±â »ý½Ä·ÂÀÌ ÀÖ´Â ºÐ¿¡°Ô praziquantelÀ» Åõ¿©ÇÏ´Â °ÍÀº Ÿ´çÇÏ´Ù°í »ý°¢ÇÕ´Ï´Ù. ¹Î¹°°í±â »ý½Ä·ÂÀÌ ¾øÀ¸¸é ´ëº¯ °Ë»ç¸¦ ÇØ º¸´Â ¼±¿¡¼­ ¸¶¹«¸®ÇÏ¸é ¾î¶»°Ú½À´Ï±î. °£ÈíÃæÁõÀ» °í·ÁÇÑ ÃÊÀ½ÆÄ ÃßÀû°Ë»ç´Â ±ÇÇÏÁö ¾Ê°í ½ÍÁö ¾Ê½À´Ï´Ù. Á» ´õ ¿¬±¸ÇØ¾ß ÇÒ topicÀ̶ó°í »ý°¢ÇÕ´Ï´Ù.


[2018-3-24. ¾Öµ¶ÀÚ Áú¹®]

¾È³çÇϽʴϱî? ±³¼ö´Ô. ¿£µµÅõµ¥ÀÌ ¾Öµ¶ÀÚÀÔ´Ï´Ù.

ÀÌƲÀü¿¡ ¹Î¹°È¸¸¦ ¸¹ÀÌ µå¼Ì´Ù°í, µð½ºÅ丶 ¾à ´Þ¶ó°í ¿À½Å ȯÀÚºÐÀÌ ÀÖ¾ú´Âµ¥¿ä. ÀÌ·± °æ¿ì ¾î¶»°Ô ÇØ¾ß ÇÏ´ÂÁö ¸ð¸£°Ú½À´Ï´Ù.

ÁÖº¯ ºÐµé²² ¹®ÀÇÇغ¸´Ï, "ºñ±Þ¿©"·Î µð½ºÅä½Ãµå ó¹æÇØ ÁÖ´Â ºÐµµ °è½Ã°í, C sinensis antibody °Ë»ç¸¦ ÇÏ¿© ¾ç¼ºÀ¸·Î ³ª¿À¸é ±Þ¿©·Î ó¹æÇϽô ºÐµµ °è½Ê´Ï´Ù. ±×·±µ¥ antibody °Ë»ç°¡ ÀÌƲÀü¿¡ ¹Î¹°È¸ µå¼Ì´Âµ¥ ³ª¿ÃÁöµµ Àǹ®ÀÔ´Ï´Ù.

°£ÈíÃæÀÌ Áõ¸íµÈ °ÍÀÌ ¾Æ´Ï°í, ¹Î¹°È¸ ¸¹ÀÌ µå¼Å¼­ ¿ì·ÁµÇ¾î ¿À½Å ºÐ²²´Â ¾î¶»°Ô ÇØ¾ß ÇÏ´ÂÁö¿ä?

[2018-3-24. ÀÌÁØÇà ´äº¯]

ÇÁ¶óÁöÄäÅÚÀº Àü¹®ÀǾàÇ°(= ó¹æ¾à)ÀÔ´Ï´Ù. ¿¹¹æ ¸ñÀûÀ¸·Î ó¹æÇÒ ¼ö ¾ø½À´Ï´Ù. ¾àÀü¿¡´Â ¾Æ·¡¿Í °°ÀÌ ³ª¿Í ÀÖ½À´Ï´Ù.

È¿´É/È¿°ú:
1. °£ÈíÃæ, ÆóÈíÃæ ¹× ÁÖÇ÷ÈíÃæ °¨¿°ÀÇ Ä¡·á
2. ¹«±¸Á¶Ãæ, À¯±¸Á¶Ãæ, ³²¾Æ¸Þ¸®Ä« ¾î·ùÁ¶Ãæ, ¿Ö¼ÒÁ¶Ãæ µî °¢Á¾ Á¶Ãæ °¨¿°ÀÇ Ä¡·á

JKMA 2013

ÇÁ¶óÁöÄäÅÚÀº Àü¹®ÀǾàÇ°À̹ǷΠó¹æÀü ¾øÀÌ ±¸ÇÒ ¼ö ¾ø½À´Ï´Ù. ÀÎÅͳݿ¡´Â ÇÁ¶óÁöÄäÅÚÀ» ºñÁ¤»óÀûÀÎ °æ·Î·Î ¾î·Æ°Ô ±¸Çß´Ù´Â ¹«¿ë´ãÀÌ ¶°µ½´Ï´Ù. ½ÉÁö¾î »ç¶÷¿ë ÇÁ¶óÁöÄäÅÚÀ» ±¸ÇÒ ¼ö ¾ø¾î¼­ µ¿¹°¿ë, Á¤È®È÷´Â ¾î·ù¿ë ÇÁ¶óÁöÄäÅÚÀ» ±¸Çß´Ù´Â »ç¿¬µµ ÀÖ½À´Ï´Ù (ºí·Î±×). "ó¹æÀüÀ» °¡Áö°í µð½ºÅä½Ãµå¶ó´Â »ç¶÷ ¸Ô´Â ¾àÀ» ±¸ÇØ¾ß Çϴµ¥ °ÅÀÇ ºÒ°¡´ÉÇÕ´Ï´Ù. ¸î¸î ¸Å´Ï¾ÆºÐµéÀº ó¹æÀüÀ» °¡Áö°í ±¸ÇϽŠºÐµéµµ ÀÖ´Â °É·Î ¾Ë°í ÀÖ½À´Ï´Ù. ´ë´ÜÇϽʴϴÙ. Á¦°¡ ±¸ÀÔÇÑ Á¦Ç°Àº ¼ö»ê¿ë ÇÁ¶óÁöÄäÅÚÀÌ°í..."

¾ç½Ä ¹°°í±â¿ë ÇÁ¶óÁöÄäÅÚ. ¿ì·°ÀÇ ¾Æ°¡¹Ì ÈíÃæÁõ Ä¡·áÁ¦·Î ¼Ò°³µÇ¾î ÀÖ½À´Ï´Ù.

ºí·Î±×

¹®ÀÇÇϽŠ¹Ù¿Í °°ÀÌ ¿¹¹æ ¸ñÀûÀ¸·Î ÇÁ¶óÁöÄäÅÚÀ» ¸Ô°í ½Í´Ù°í ã¾Æ¿À´Â ºÐµé¿¡°Ô ¾î¶»°Ô ÇØ¾ß ÇÏ´ÂÁö °í¹ÎÀÔ´Ï´Ù. "ºñ±Þ¿©·Î µð½ºÅä½Ãµå¸¦ ó¹æÇØÁÖ´Â ºÐ"µµ °è½Å´Ù°í Çߴµ¥, ±Þ¿©·Î ó¹æÇØ¾ß ÇÏ´Â ¾àÀ» ºñ±Þ¿©·Î ó¹æÇÏ´Â °ÍÀº ¾ö¿¬ÇÑ ºÒ¹ýÀ¸·Î Àý´ë·Î Çؼ­´Â ¾ÈµÇ´Â ÀÏÀÔ´Ï´Ù.

Ç×ü °Ë»ç¸¦ ½ÃÇàÇÏ¿© ¾ç¼ºÀ¸·Î ³ª¿À¸é ó¹æÇÑ´Ù´Â ÃʽÄÀº ÁÁÁö ¾Ê½À´Ï´Ù. (1) ÀûÀÀÁõ ¾øÀÌ ±×³É Ç×ü °Ë»ç¸¦ ÇÏ¿© ¾ç¼ºÀ¸·Î ³ª¿Â´Ù°í ±â»ýÃæ °¨¿°ÁõÀ» Áø´ÜÇÒ ¼ö ¾ø°í, (2) °Ë»ç¸¦ ÇÑ´Ù¸é Ç×ü °Ë»ç°¡ ¾Æ´Ï¶ó ´ëº¯À» ÅëÇÑ ±â»ýÃæ Ãæ¶õ °Ë»ç¸¦ ÇÏ´Â °ÍÀÌ ¿Ç°í, (3) ¾àÀ» ´Þ¶ó°í ¿À½Å ºÐ²² °Ë»ç¸¦ ÇÏ°í ¸çÄ¥ ÈÄ °á°ú¸¦ º¸·¯ ¿À¶ó°í ¸»ÇÏ´Â °ÍÀÌ ½±Áö ¾Ê°í, (4) °Ë»ç °á°ú À½¼ºÀÌ¸é ¾àÀ» ó¹æÇÒ ¸íºÐÀÌ ¾ø¾îÁö±â ¶§¹®ÀÔ´Ï´Ù. °Ô´Ù°¡ ¸çÄ¥ Àü¿¡ ¹Î¹°°í±â¸¦ ¸ÔÀº °æ¿ì´Â °¨¿°ÀÌ µÇ´õ¶óµµ ´çÀåÀÇ Ç×ü °Ë»ç³ª ´ëº¯ °Ë»ç¿¡¼­ ±â»ýÃæÁõÀÌ È®ÀεÇÁö´Â ¾ÊÀ» °Í °°½À´Ï´Ù.

¿¹¹æ ¸ñÀûÀÇ ÇÁ¶óÁöÄäÅÚÀÇ È¿°úµµ ¸íÈ®ÇÏÁö ¾Ê½À´Ï´Ù (Âü°í: 2012³â ¾Öµ¶ÀÚ Áú¹®°ú ´äº¯). ¹Î¹°È¸¿Í praziquantelÀ» µ¿½Ã¿¡ ¸Ô¾úÀ» ¶§ ¼ÒÀå¿¡¼­ Å»³¶ÇÑ À¯Ãæ¿¡°Ô ÇÁ¶óÁöÄäÅÚÀÌ Àß Àü´ÞµÇ´ÂÁö pharmacokineticsÀ» ¾Ë ¼ö ¾ø´Ù´Â °ÍÀÔ´Ï´Ù. ÇÁ¶óÁöÄäÅÚÀ» ÀÌ¿ëÇÑ mass control programÀÌ ½ÇÆÐÇÑ ¹Ùµµ ÀÖ½À´Ï´Ù (Parasitol Int 2012). ¾Æ¸¶µµ Àç°¨¿°ÀÌ ¿øÀÎÀÏ °ÍÀÔ´Ï´Ù. "¿¹¹æ¾àÀ» ãÁö ¸»°í ¾ÕÀ¸·Î´Â ¹Î¹°È¸¸¦ µå½ÃÁö ¸¶¼¼¿ä"¶ó°í ±³À°ÇÏ´Â °ÍÀÌ ´õ¿í Áß¿äÇÕ´Ï´Ù. ¿¹¹æ ¸ñÀûÀ¸·Î ó¹æÇÒ ¼ö ¾ø½À´Ï´Ù.

¿äÄÁµ¥ µÑ ÁßÀÇ ÇϳªÀÔ´Ï´Ù.

1) Say No - "¿¹¹æ¸ñÀûÀ¸·Î ó¹æÇÒ ¼ö ¾ø´Â ¾àÀÔ´Ï´Ù. Á˼ÛÇÕ´Ï´Ù. ºÒ¹ý ó¹æÀ» ÇÒ ¼ö´Â ¾ø½À´Ï´Ù."¶ó°í µü Àß¶ó ¸»Çϱâ

2) ´« µü °¨°í ó¹æÇϱâ - Àǹ«±â·Ï¿¡´Â "¹Î¹°°í±âȸ ¸¹ÀÌ µå½É. ¿¹¹æ¾à ó¹æ ¿øÇϽÉ. r/o Clonorchis sinensis infection"À̶ó°í ¾²°í praziquantel 8 table (¾Æħ 3¾Ë, Á¡½É 3¾Ë, Àú³á 2¾Ë) ó¹æÇϱâ.

°á±¹ °¢ÀÚ°¡ óÇÑ Áø·á ȯ°æ¿¡ µû¶ó ¼±ÅÃÇÒ ¼ö ¹Û¿¡ ¾øÀ» °Í °°½À´Ï´Ù. Àú´Â º¸Åë µÎ¹ø°¸¦ ¼±ÅÃÇØ¾ß ÇÏ´Â »óȲÀÔ´Ï´Ù. ´Ù¸¸, ´« µü °¨°í ó¹æÇÑ °æ¿ì´Â (1) »è°¨ÀÇ À§ÇèÀÌ ÀÖÀ¸¸ç, (2) ºÎÀÛ¿ë ¹ß»ý ½Ã ó¹æÇÑ Àǻ翡°Ô ºñ³­ÀÌ µ¹¾Æ¿Ã ¼ö ÀÖ½À´Ï´Ù.

Àç·®±ÇÀÌ °ÅÀÇ ¾ø´Â ÀÇ·á ȯ°æ(= off-label ó¹æÀ» ºÒ¹ýÀ¸·Î °£ÁÖÇÏ´Â ÀÇ·áȯ°æ)¿¡¼­ ÀûÀýÇÑ Áø·á´Â Âü ¾î·Á¿î ÀÏÀÔ´Ï´Ù. Àǻ翡°Ô Á» ´õ ¸¹Àº Àç·®±ÇÀÌ ÁÖ¾îÁ®¾ß Á¤»óÀûÀÎ Áø·á°¡ °¡´ÉÇÒ °Í °°½À´Ï´Ù.


[2019-11-10. ¾Öµ¶ÀÚ Áú¹®]

°£ÈíÃæ Ä¡·áÁ¦ÀÎ fraziquantel Åõ¿©ÈÄ anti clonorchis sinensis IgG antibody À» ´Ù½Ã Àç°ËÇÏ¿© ÀÌÀüº¸´Ù ¿ª°¡°¡ ³·¾ÆÁö´Â °ÍÀ» È®ÀÎÇØ¾ß ÇÏ´ÂÁö¿ä? ÀÌÀü ±¹³» ³í¹®À» ã¾Æº¸´Ï 7°³¿ùºÎÅÍ 18°³¿ùÈÄ¿¡¾ß Ç×ü ¿ª°¡°¡ °¨¼ÒÇÑ´Ù´Â º¸°í°¡ Àִµ¥ Áø·á¸¦ ÇÏ¸ç ¾àÀÇ ¹ÝÀÀÀ» º¸±âÀ§ÇØ anti clonorchis sinensis IgG antibody À» ´Ù½Ã Àç°ËÇÏ´Â °ÍÀÌ ÇÊ¿äÇÑÁö Á¶¾ðºÎŹµå¸³´Ï´Ù.

[2019-11-10. ÀÌÁØÇà ´äº¯]

±×³É stool examÀ» Çϸé ÃæºÐÇÒ °Í °°½À´Ï´Ù. °£ÈíÃæ Ç×üÀÇ Áø´ÜÀû °¡Ä¡³ª ¿ª°¡ º¯È­ÀÇ ÃßÀû°Ë»ç¿¡¼­ÀÇ Àǹ̴ Ȯ¸³µÇÁö ¾Ê¾Ò´Ù°í »ý°¢ÇÕ´Ï´Ù.

°£ÈíÃæ Ç×ü¿¡ ´ëÇÑ ¸®ºä 2°³¸¦ ÃßõÇÕ´Ï´Ù. Âü°íÇϱ⠹ٶø´Ï´Ù. Âü°í¹®Çå 1, Âü°í¹®Çå 2


[References]

1) EndoTODAY ±â»ýÃæÇÐ

2) ÈíÃæ °¨¿°Áõ (Áúº´°ü¸®º»ºÎ °¨¿°º´½ÇÇè½ÇÁø´Ü. PDF 0.5M)

3) ÀÓÀçÈÆ ±³¼ö´Ô²²¼­ ´ëÇѼÒÈ­±âÇÐȸÁö¿¡ ±â°íÇÑ È¸°í·ÏÀÔ´Ï´Ù. ¸Å¿ì Àç¹ÌÀÖ½À´Ï´Ù. ²À Àо¼¼¿ä.

³ª´Â ÀÌ Áúȯ¿¡ Èï¹Ì¸¦ °®°Ô µÇ¾î ¿Ü±¹ÇÐȸ¿¡ °¡¼­ °­ÀÇÇÏ¸é ¿Ü±¹ÇÐÀÚµéÀÌ Èï¹Ì·Ó°Ô °­ÀǸ¦ µè°í¼­, Çѱ¹¿¡´Â ¿Ö ±×·± ÁúȯÀÌ ±×¸® ¸¹À¸³Ä°í ¹¯´Â´Ù. ¿ì¸®³ª¶ó¿¡ °£ÈíÃæÁõ ȯÀÚ°¡ ¸¹°í ±× ¶§¹®¿¡ ´ã°ü°á¼®µµ »ý±â°í, °Å±â¼­ ´ã°ü ³» À¯µÎÁ¾¾çÀÌ ¹ß»ýÇϱ⠶§¹®À̶ó°í ¼³¸íÇÏ¿´´Ù. âÇÇÇÏ´Ù. ³Ê °Å¸Ó¸® ¶§¹®À̾ß, ÀÌ ¾Ç¸¶. ¾Ç, ¾Ï(äÂ, äß)ÀÇ ¾¾¾Ñ

4) [2016-2-15. KBS] °­ Àα٠ÁֹΠ±â»ýÃæ °¨¿° ÁÖÀÇ¡¦'ȸ' ±Ý¹°

ÇöÀç ¿ì¸®³ª¶ó¿¡¼­ °¡Àå ÈçÇÑ Àå³» ±â»ýÃæÀº °£ÈíÃæÀÔ´Ï´Ù. ¹Î¹°°í±â¸¦ ³¯·Î ¸Ô°í °¨¿°µË´Ï´Ù. ¾Æ¹«·¡µµ 4´ë°­ À¯¿ª¿¡ ¸¹½À´Ï´Ù. KBS º¸µµÀε¥ ³»¿ëÀÌ Á¤È®ÇÏ¿© ¿©·¯ºÐ ¸ðµÎ º¸¼ÌÀ¸¸é ÇÕ´Ï´Ù (±â»ç ¸µÅ©).

¿¹¹æÀ» À§Çؼ± ¹Î¹°°í±â¸¦ ³¯·Î ¸ÔÁö ¾Ê´Â °Ô °¡Àå Áß¿äÇÕ´Ï´Ù. Á¶¸®±â±¸µµ ¶ß°Å¿î ¹°¿¡ 7ÃÊ ÀÌ»ó ´ã°¡ ±ú²ýÀÌ ¼Òµ¶ÇØ¾ß ÇÕ´Ï´Ù. "¹Î¹°°í±â ¾È¿¡ ÀÖ´Â ¾Ö¹ú·¹, µµ¸¶¿¡¼­ Á¶¸®ÇÒ ¶§ °Å±â ÀÌÁ¦ ¹¯¾îÀÖÁÒ. ±×·¡¼­ º»ÀÎÀº ³¯·Î ¸ÔÁö ¾Ê¾Ò´Ù°í ÇÏ´õ¶óµµ Á¶¸®ÇÏ´Â °úÁ¤ Áß¿¡ µé¾î°¥ ¼ö°¡ ÀÖ½À´Ï´Ù." ±¹³» ±â»ýÃæ °¨¿°ÀÚ´Â 130¸¸ ¸íÀ¸·Î Ãß»êµÇ°í ÀÖ°í ÀÌ °¡¿îµ¥ 70% ÀÌ»óÀÌ ¹Î¹°°í±â¸¦ ³¯·Î ¸Ô°í °¨¿°µÆ½À´Ï´Ù.



© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.